Copenhagen Oe

• IMPACT – the introduction of mycotic prophylaxis at cystectomy trial. Recruiting
  2023-506226-36-00 6 2024-06-23 Fungal infection
• PreVent-ACaLL Recruiting
  2024-511072-33-00 4 2024-06-12 Chronic Lymphocytic Leukemia
• Ebastine in combination with docetaxel or as a treatment for metastatic castration-resistant prostate cancer Recruiting
  2024-518035-11-01 4 2024-06-02 metastatic castration-resistant prostate cancer (mCRPC)
• Phase 1, First-in-Human Study to Assess the Safety, Tolerability and Anti-tumor Activity of CDR404 in HLA-A*02:01 Participants with MAGE-A4 … Recruiting
  2023-508808-38-00 1 2024-05-29 Solid tumors
• C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL … Recruiting
  2023-507871-23-00 5 2024-05-27 Relapsed/Refractory Multiple Myeloma
• Examining the impact of propranolol on preoperative anxiety and on tumorigenic changes in patients with pancreatic ductal adenocarcinomas: a … Recruiting
  2023-506553-37-00 4 2024-04-23 Pancreatic ductal adenocarcinoma (PDAC)
• A trial to learn if volrustomig is safe and efficacious in women and young adults with locally advanced cervical cancer. Recruiting
  2023-504374-38-00 5 2024-04-12 Locally advanced cervical cancer
• HOVON 165 CLL: A prospective randomized phase I/II trial of venetoclax treatment (26 cycles) with 6 cycles or 12 cycles of epcoritamab in pa … Recruiting
  2022-500305-40-00 9 2024-04-10 Small Lymphocytic Lymphoma
• RADAR: A randomised phase III trial with a PET response adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previousl … Recruiting
  2022-500031-37-00 5 2024-04-08 ​ stage IA/IIA Hodgkin lymphoma
• A clinical trial comparing a new treatment (MK-5684) to approved medication for advanced prostate cancer after prior hormonal therapy and ch … Recruiting
  2023-504899-25-00 5 2024-04-04 Metastatic castration resistant prostate cancer
• Phase 3 study of adjuvant V940 and Pembrolizumab in resected Stage II, IIIA, IIIB NSCLC Recruiting
  2023-504923-20-00 5 2024-04-04 Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer
• SGLT2 inhibitor TrEatment iN patients awaiting cOronary arTery bYpass surgery to reduce Post-opErative atrial fibrillation and kidney injury … Recruiting
  2023-505375-75-00 5 2024-04-04 Onset of Atrial Fibrillation and Acute Kidney Injury after coronary ar
• Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock f … Recruiting
  2024-510892-40-00 6 2024-02-29 Acute myocardial infarction complicated by cardiogenic shock
• Can patients with atrial fibrillation discontinue anticoagulant therapy after cardiac surgery: The ATLAAC trial Recruiting
  2022-502986-92-00 6 2024-02-27 Atrial fibrillation
• A Phase I Study of VVD-133214 Alone and in Combination in Participants with Advanced Solid Tumors Recruiting
  2023-503170-20-01 1 2024-02-26 Advanced solid tumors
• SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting
  2023-507617-96-01 6 2024-02-14 Pyogenic vertebral osteomyelitis
• GLYCOGEN RESPONSE TO ENZYME REPLACEMENT THERAPY IN POMPE DISEASE Recruiting
  2023-508000-37-01 6 2024-02-13 Pompe Disease
• DAN-WAR-D - Danish Warfarin-Dialysis Study: Safety and efficacy of warfarin in patients with atrial fibrillation on dialysis -A nationwide p … Recruiting
  2022-502500-75-00 6 2024-01-30 Atrial fibrillation
• STEPS-EA trial Recruiting
  2023-504905-36-00 11 2024-01-11 Strictures after esophageal atresia repair
• Mitapivat in Membranopathies Recruiting
  2023-503271-24-01 4 2023-12-29 erythrocyte membranopathies
• A study to test how effective belumosudil tablets are for treating adult participants with chronic lung allograft dysfunction Recruiting
  2023-503462-23-00 5 2023-12-28 Lung transplant rejection
• Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n … Recruiting
  2023-504637-42-01 6 2023-12-21 aortic valve stenosis
• Prophylaxis Study of Marstacimab in Pediatric Hemophilia Participants With or Without Inhibitors Recruiting
  2022-500495-65-00 5 2023-12-06 Haemophilia
• A Phase 1, Open-Label, Multicenter Study of INCA033890 in Participants with Advanced or Metastatic Solid Tumors Recruiting
  2022-502456-31-00 1 2023-11-30 Advanced or metastatic solid tumors

Showing 265–288 of 671 trials